What happened: Scientists in Cambridge have conducted the first human trial of a vaccine developed using artificial intelligence technology. The vaccine aims to improve the speed and precision of vaccine design.
Why it matters:
- This innovation could accelerate vaccine development for future diseases.
- It may lead to more effective vaccines tailored to specific pathogens.
MNN Take: Using AI to design vaccines represents a new approach that could enhance how quickly and accurately vaccines are created, potentially benefiting public health worldwide.
Sources: BBC Health (Lifestyle)